Upload Avatar (500 x 500)
Ping Zhou
zping@shmu.edu.cn
Chinese, Japanese
Shanghai
Fudan University
Basic Medical Sciences
  • 1978.11—1983.07 Bachelor's in Clinical Medicine: China Medical University
  • 1992.08—1995.07 Master's in Pathophysiology: China Medical University
  • 1996.01—1997.03 Research Student in Anatomy: Shiga University of Medical Science, Japan
  • 1997.04—2001.03 PhD in Bioinformatics Regulation: Shiga University of Medical Science, Japan
  • 1983.08—1985.10 - Jinzhou Medical University First Affiliated Hospital - Physician
  • 1985.11—1992.7 - Jinzhou Medical University Basic Department - Assistant Lecturer, Lecturer
  • 2001.04—Present - Fudan University Basic Medical College - Associate Professor, Professor
  • 2012: March 8th Red Flag Bearer, Fudan University
  • 2011: Excellent Teacher, Shanghai Medical College of Fudan University
  • 2008: Third Prize of Chinese Medical Science and Technology Award, Chinese Medical Association
  • 2000: Shiga Science Research Grant, Shiga Science Research Committee, Japan
  • 1996—2001: Full Government Scholarship, Ministry of Education, Japan
Molecular mechanisms of tumor invasion, metastasis, and drug resistance
Development, screening, and mechanism of action of anti-cancer drugs
Pathogenesis and experimental treatment of cardiovascular diseases
  • Long intergenic non-coding RNA APOC1P1-3 inhibits apoptosis by decreasing α-tubulin acetylation in breast cancer, X-H Liao, J-G Wang, L-Y Li, D-M Zhou, K-H Ren, Y-T Jin, L Lv, J-G Yu, J-Y Yang, Q Lu, Q Zou, J Yu, X-P Liu, P Zhou, 2016
  • Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway, Jiangang Yu, Xue Wang, Qi Lu, Jigang Wang, Luying Li, Xiaohong Liao, Wei Zhu, Lei Lv, Xiuling Zhi, Jerry Yu, Yiting Jin, Qiang Zou, Zhouluo Ou, Xiuping Liu, Ping Zhou, 2018
  • Ecto-5′-nucleotidase (CD73) attenuates inflammation after spinal cord injury by promoting macrophages/microglia M2 polarization in mice, Shun Xu, Wei Zhu, Minghao Shao, Fan Zhang, Ji Guo, Haocheng Xu, Jianyuan Jiang, Xiaosheng Ma, Xinlei Xia, Xiuling Zhi, Ping Zhou, Feizhou Lu, 2018
  • Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma, Shali S, Yu J, Zhang X, Wang X, Jin Y, Su M, Liao X, Yu J, Zhi X, Zhou P, 2019
  • Long non-coding RNA RACGAP1P promotes breast cancer invasion and metastasis via miR-345-5p/RACGAP1-mediated mitochondrial fission, Danmei Zhou, Kehan Ren, Meili Wang, Jigang Wang, Ermin Li, Chenjian Hou, Ying Su, Yiting Jin, Qiang Zou, Ping Zhou, Xiuping Liu
  • lncRNA APOC1P1-3 promoting anoikis-resistance of breast cancer cells, Qi Lu, Li Wang, Yabiao Gao, Ping Zhu, Luying Li, Xue Wang, Youping Jin, Xiuling Zhi, Jerry Yu, Xin Li, Xingjun Qin, Ping Zhou, 2021
  • tRNA-derived fragment tRF Lys-CTT-010 promotes triple-negative breast cancer progression by regulating glucose metabolism via G6PC, Ping Zhu, Jingjing Lu, Xiuling Zhi, Yue Zhou, Xue Wang, Chaofu Wang, Yabiao Gao, Xiufen Zhang, Jerry Yu, Yang Bai Sun, Ping Zhou, 2021
  • Long noncoding RNA ENST00000508435 promotes migration of breast cancer via FXR 1, Luying Li, Youping Jin, Xue Wang, Li Wang, Yangbai Sun, Yihong Luo, Xiaojian Ni, Qi Lu, Wenbo Wei, Xiuling Zhi, Jerry Yu, Wei Zhu, Ping Zhou, 2021
  • Loss of SPTBN1 suppresses autophagy via SETD7-mediated YAP methylation in hepatocellular carcinoma initiation and development, Shuyi Chen, Hujie Wu, Zhengyang Wang, Mengping Jia, Jieyu Guo, Jiayu Jin, Xiaobo Li, Dan Meng, Ling Lin, Aiwu Ruth He, Ping Zhou, Xiuling Zhi, 2022
  • Anti-cancer Drug Anlotinib Promotes Autophagy and Apoptosis in Breast Cancer, Shuyi Chen, Yabiao Gao, Ping Zhu, Xue Wang, Linzi Zeng, Youping Jin, Xiuling Zhi, Huanjun Yang, Ping Zhou, 2022
Tumor Invasion Metastasis Drug Resistance Anti-Cancer Drugs Screening Mechanism Cardiovascular Diseases Pathogenesis Treatment

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.